Pfizer Loses Bid to Dismiss Fen-Phen Lung Ailment Suits

Pfizer Inc., whose Wyeth unit reserved more than $21 billion to settle lawsuits over the fen-phen diet drugs, lost its bid to have claims that the pills caused a fatal disease years after users stopped taking them thrown out.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.